Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been given a consensus recommendation of “Buy” by the five brokerages that are covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the stock […]
Contrasting Centessa Pharmaceuticals (NASDAQ:CNTA) & Larimar Therapeutics (NASDAQ:LRMR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs reiterated their outperform rating on shares of Larimar Therapeutics (NASDAQ:LRMR – Free Report) in a research report released on Wednesday, Zacks.com reports. Leerink Partnrs also issued estimates for Larimar Therapeutics’ FY2026 earnings at ($2.65) EPS, FY2027 earnings at ($2.41) EPS and FY2028 earnings at ($1.75) EPS. A number of other research analysts also […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report)’s stock price dropped 4.8% during mid-day trading on Tuesday . The stock traded as low as $11.76 and last traded at $11.80. Approximately 33,993 shares changed hands during trading, a decline of 95% from the average daily volume of 625,641 shares. The stock had previously closed at […]